|
|
Ortho Organizers, Inc. (“Ortho” or the “Company”) announced today that it has been acquired by an investor group that includes Ampersand Ventures (“Ampersand”), Celerity Partners and a new executive team. |
|
|
|
Assay Designs, Incorporated (“Assay Designs") announced today that it has purchased Stressgen Bioreagents Corporation (“Stressgen”), which recently acquired the reagents business of Stressgen Biotechnologies Corporation (TSX:SSB) in an asset purchase transaction funded by Ampersand Ventures (“Ampersand”). Based in Victoria, British Columbia, Stressgen develops and markets antibodies, proteins and related kits to life sciences researchers worldwide. |
|
|
|
Assay Designs, Incorporated (“the Company") announced today that that it recently received a $5 million Series A equity investment from Ampersand Ventures (“Ampersand”). |
|
|
|
Stressgen Biotechnologies (TSX:SSB) (“the Company”) announced today that it has completed its previously announced sale of its bioreagent business to Stressgen Bioreagents Corporation, a newly-formed company funded by Ampersand Ventures (“Ampersand”), for approximately C$8.0 million. |
|
|
|
Talecris to apply innovative approach to its inherited, 60-year legacy of providing life-saving and life enhancing plasma-derived therapeutic proteins |
